Amundi - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Amundi ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$127,000
+24.5%
1,9480.0%0.00%
Q2 2022$102,000
-23.3%
1,9480.0%0.00%
Q1 2022$133,000
-10.1%
1,9480.0%0.00%
Q4 2021$148,000
-26.0%
1,9480.0%0.00%
Q3 2021$200,000
+17.0%
1,9480.0%0.00%
Q2 2021$171,0001,9480.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders